Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield,

The clinical data from the Phase 1b trial showed that: Serum binding antibody responses to the protective antigen of Bacillus anthracis, the bacterium …, The clinical data from the Phase 1b trial showed that: Serum binding antibody responses to the protective antigen of Bacillus anthracis, the bacterium …, Read More

Scroll to Top